ELITE PHARMACEUTICALS INC /NV/ Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2019 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $498K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $498K Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $554K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $612K +$612K Mar 31, 2024 10-K 2024-07-01
Q4 2023 $727 +$706 Dec 31, 2023 10-Q 2024-02-14
Q1 2023 $108* -$156K Mar 31, 2023 10-Q 2023-08-14
Q4 2022 $21.00* -$172K Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $202* -$173K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $141K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $156K Mar 31, 2022 10-K 2022-06-29
Q4 2021 $172K Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $174K Sep 30, 2021 10-Q 2021-11-15
Q2 2020 $176K +$134K +322% Jun 30, 2020 10-Q 2021-08-16
Q4 2019 $27.2K Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $34.1K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $41.6K Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.